MedTech investors are facing an increasingly difficult choice. On one side is Abbott Laboratories (NYSE:ABT), a diversified ...

Premium healthcare stocks often trade at elevated valuations for very different reasons. Thermo Fisher’s (NYSE:TMO) ...

Intuitive Surgical is in focus as readers track pipeline progress, procedure demand, and company execution within healthcare ...

Intuitive Surgical ISRG recently announced it will expand its manufacturing presence in Asia Pacific with a new facility in ...

Healthcare investors often face a difficult decision when choosing between companies with very different paths to growth.

The big question is where Intuitive Surgical goes from here; for investors, the future always matters much more than the past. I'd argue that Intuitive isn't going away, because it already has an ...

Intuitive Surgical's stock is poised to return over 60% in 2024, driven by strong tailwinds in the MedTech industry and elevated capital investments. The da Vinci 5 system has been well received, with ...

Intuitive (NASDAQ: ISRG), the U.S. maker of the da Vinci surgical robot, will invest more than RM2 billion over five years to ...

Intuitive Surgical remains a key healthcare technology company as innovation, robotic surgery adoption and operational trends ...

Intuitive Surgical (ISRG)'s Q2/26 surge shows a moat and recurring revenue, but a rich valuation keeps it a Hold. Read here ...

Intuitive, a leader in robotic-assisted surgery (RAS), announced two studies showing that RAS improves access to high-quality care and enhances patient outcomes, particularly in areas with limited ...